Research shows that GLP-1 medications reduce waist circumference by an average of 5.93 centimeters, while diet alone reduces it by 3.46 centimeters, according to a 2026 meta-analysis of 21 randomized controlled trials involving 3,196 adults. Exercise alone showed less consistent results. These findings suggest that GLP-1 drugs and dietary changes are the most effective approaches for reducing belly fat linked to heart disease and diabetes.
A major analysis of 21 studies involving over 3,000 people shows that GLP-1 medications and diet changes both effectively reduce waist circumference—a key measure of dangerous belly fat linked to heart disease and diabetes. According to Gram Research analysis, GLP-1 drugs shrank waist size by nearly 6 centimeters on average, while diet alone reduced it by about 3.5 centimeters. Interestingly, exercise by itself showed less consistent results. The findings suggest that waist circumference is a practical way to track whether weight-loss treatments are actually working to reduce the harmful fat stored around your organs.
Key Statistics
A 2026 meta-analysis of 21 randomized controlled trials involving 3,196 adults found that GLP-1 receptor agonist medications reduced waist circumference by 5.93 centimeters on average, significantly more than diet-only interventions which reduced it by 3.46 centimeters.
According to research reviewed by Gram, all weight-loss interventions combined showed an average waist circumference reduction of 4.36 centimeters across 27 treatment comparisons in the 2026 meta-analysis, with effects ranging from 1.73 to 6.98 centimeters depending on the intervention type.
The 2026 meta-analysis found that changes in waist circumference were positively associated with changes in visceral adipose tissue (dangerous belly fat), suggesting that waist measurement is a practical marker for tracking whether treatments are reducing harmful fat around organs.
Exercise-only interventions showed more variable effects on waist circumference compared to GLP-1 medications and diet in the 2026 analysis of 21 studies, with subgroup differences not reaching statistical significance.
The Quick Take
- What they studied: How well different weight-loss methods (diet, exercise, diet plus exercise, and GLP-1 medications) reduce waist circumference, which is belly fat that poses serious health risks.
- Who participated: 3,196 adults across 21 randomized controlled trials published between 2010 and 2025. These are the gold-standard studies where people are randomly assigned to different treatments.
- Key finding: GLP-1 medications reduced waist circumference by 5.93 centimeters on average, while diet alone reduced it by 3.46 centimeters. All interventions combined showed an average reduction of 4.36 centimeters.
- What it means for you: If you’re trying to lose belly fat, GLP-1 medications appear most effective, followed by dietary changes. Exercise alone may be less reliable for reducing waist circumference specifically, though it has other health benefits. Talk to your doctor about which approach fits your situation.
The Research Details
Researchers searched medical databases for high-quality studies (randomized controlled trials) published over 15 years that measured changes in waist circumference. They followed strict guidelines to ensure they included only the most reliable evidence. The team combined data from 27 different treatment comparisons across 21 studies, using statistical methods that account for differences between studies.
They looked at four main types of interventions: diet changes alone, exercise alone, diet combined with exercise, and GLP-1 receptor agonist medications (a newer class of diabetes and weight-loss drugs). The researchers then compared how much each approach reduced waist circumference and explored whether certain factors—like a person’s starting weight, age, or baseline measurements—predicted who would benefit most.
To ensure the results were trustworthy, they checked for publication bias (the tendency for positive studies to be published more often) and examined whether smaller studies showed different results than larger ones.
This systematic approach is important because it combines evidence from many studies rather than relying on just one. Individual studies can have different results due to chance or differences in how they were conducted. By pooling data from thousands of participants across multiple studies, researchers get a clearer picture of what actually works. This meta-analysis also helps identify which treatments work best and for whom, which is crucial for doctors making treatment recommendations.
This is a high-quality analysis published in a peer-reviewed journal and conducted following strict international guidelines (PRISMA 2020). The researchers included only randomized controlled trials, which are considered the gold standard for testing treatments. However, they noted possible small-study effects, meaning smaller studies sometimes showed different results than larger ones. The findings about which factors predict treatment success should be interpreted cautiously since they came from study-level data rather than individual patient data.
What the Results Show
Across all 27 treatment comparisons, interventions reduced waist circumference by an average of 4.36 centimeters. This may seem modest, but research shows that even small reductions in waist circumference significantly lower the risk of heart disease and diabetes.
When researchers looked at specific treatments, GLP-1 medications were the most effective, reducing waist circumference by 5.93 centimeters on average. Diet-only interventions came in second, reducing waist circumference by 3.46 centimeters. These findings were statistically significant, meaning they’re unlikely to be due to chance.
Exercise-only interventions and the combination of diet plus exercise showed more variable results—some studies found good results while others found smaller effects. The differences between these groups weren’t statistically significant, suggesting that exercise’s effect on waist circumference is less predictable than diet or medication.
The researchers also found that changes in waist circumference were connected to changes in visceral adipose tissue (the dangerous fat surrounding organs). This suggests that waist circumference is a useful marker for tracking whether treatments are actually reducing the harmful type of fat.
The analysis explored whether certain baseline characteristics predicted who would benefit most from treatment. Factors like starting weight, age, and initial body measurements showed potential associations with waist circumference reduction, but these findings should be interpreted cautiously. The researchers noted that more detailed individual-level data would be needed to make confident predictions about who responds best to each treatment. The study also found evidence of small-study effects, where smaller studies sometimes reported larger benefits than larger studies, suggesting some caution in interpreting results.
This analysis builds on previous research showing that GLP-1 medications and lifestyle changes reduce overall body weight. However, it provides new clarity on their specific effects on waist circumference—a particularly important measure because belly fat is more strongly linked to heart disease and diabetes than fat stored elsewhere. The finding that GLP-1 medications outperform exercise alone for reducing waist circumference is noteworthy, as it suggests these drugs may have advantages beyond simple weight loss. The connection between waist circumference changes and visceral fat changes supports using waist measurement as a practical tracking tool.
The analysis combined data from studies conducted over 15 years, during which treatment protocols and measurement methods may have varied. Some studies were small, which can lead to less reliable results. The researchers couldn’t analyze individual patient data, only overall study results, which limits their ability to identify exactly which people benefit most. Publication bias may exist—studies showing positive results are more likely to be published than those showing no effect. Finally, most studies were relatively short-term, so it’s unclear whether these benefits persist over years.
The Bottom Line
Strong evidence supports using GLP-1 medications or dietary changes to reduce waist circumference and the associated health risks. Moderate evidence suggests that exercise alone may be less effective for reducing waist circumference specifically, though exercise has many other health benefits and should remain part of a healthy lifestyle. The best approach likely combines multiple strategies tailored to your individual situation. Discuss with your healthcare provider which option is appropriate for you, considering your health status, preferences, and medical history.
Anyone concerned about belly fat and heart disease risk should pay attention to these findings, particularly people with type 2 diabetes or prediabetes. Those considering GLP-1 medications should know they appear effective for reducing waist circumference. People who prefer dietary approaches can expect meaningful results. Those relying solely on exercise for waist reduction may want to add dietary changes. People with certain medical conditions should consult their doctor before starting any new treatment.
Most studies in this analysis lasted several months to a year. Significant waist circumference reductions typically appear within 3-6 months of starting treatment, though individual results vary. Long-term benefits beyond one year are less well-studied, so maintaining the treatment approach is important for sustained results.
Frequently Asked Questions
Does GLP-1 medication work better than diet for losing belly fat?
According to a 2026 meta-analysis of 3,196 adults, GLP-1 medications reduced waist circumference by 5.93 centimeters on average, compared to 3.46 centimeters for diet alone. GLP-1 appears more effective, but diet still produces meaningful results and may be preferred by some people.
Is exercise alone enough to reduce waist circumference?
A 2026 analysis of 21 studies found that exercise-only interventions showed inconsistent results for reducing waist circumference, with effects varying significantly between studies. Combining exercise with dietary changes or considering GLP-1 medication may be more reliable for reducing belly fat.
Why is waist circumference important to measure?
Waist circumference measures belly fat, which is more strongly linked to heart disease and diabetes than fat stored elsewhere. Research shows that reducing waist circumference by even a few centimeters significantly lowers disease risk, making it a practical health marker beyond just overall weight loss.
How quickly will I see waist circumference reduction?
Most studies in the 2026 meta-analysis lasted several months to a year. Significant reductions typically appear within 3-6 months of starting treatment, though individual results vary. Consistency with your chosen approach—whether diet, exercise, or medication—is key to sustained progress.
Can I combine diet and exercise instead of using GLP-1 medication?
A 2026 analysis found that combining diet and exercise showed variable results, with less consistent waist circumference reduction than GLP-1 medication or diet alone. However, this combination has other health benefits and may work well for some people. Discuss your options with your healthcare provider.
Want to Apply This Research?
- Measure waist circumference monthly at the same time of day, at the level of your belly button, using the same measuring tape. Record the measurement in your app to track progress toward your goal. A reduction of even 1-2 centimeters per month indicates the treatment is working.
- If using the app to support dietary changes, log meals daily and set a specific calorie or macronutrient target. If tracking GLP-1 medication use, log doses and any side effects. If focusing on exercise, track workouts but recognize that diet changes may be needed for waist circumference reduction.
- Create a dashboard showing waist circumference trend over time alongside your chosen intervention (diet adherence, exercise frequency, or medication compliance). Set monthly check-ins to review progress and adjust your approach if needed. Share trends with your healthcare provider during regular visits to ensure your treatment plan is working.
This analysis summarizes research findings and should not replace professional medical advice. GLP-1 medications are prescription drugs with potential side effects and are not appropriate for everyone. Before starting any weight-loss treatment, diet change, or exercise program, consult with your healthcare provider to determine what’s safe and appropriate for your individual health situation. Results vary between individuals, and this research represents average effects across groups. If you experience any adverse effects from treatment, contact your healthcare provider immediately.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.